Market Disruptor

more than just a hangover cure

Backed by clinical research and experienced leadership, unbuzzd is positioned to capitalize on the growing demand for wellness and alcohol recovery products.

40%

Faster Detox

Clinically shown to accelerate alcohol elimination.

4x

Less Headache

Dramatically reduces headache severity during recovery.

investment opportunity

Unbuzzd at a Glance

Public Company

A fully reporting public company committed to transparency, accountability, and long-term growth.

Patented Innovation

unbuzzd owns valuable intellectual property and patents that help strengthen its competitive position.

Top Research Team

Supported by a leading pharmaceutical research and development team with extensive industry expertise.

Published Results

Successfully Proven by Clinical Trials

unbuzzd dramatically and rapidly reduced blood alcohol concentration in study participants. The rate at which BAC was lowered was, on average for most participants, more than 40 percent faster within 30 minutes of consuming unbuzzd compared to control subjects. This faster reduction of BAC after consuming unbuzzd was both statistically significant compared to placebo and was observed at each subsequent measurement of BAC over a four-hour period.
Study participants reported statistically significant improvement in alertness as soon as 30 minutes after consuming unbuzzd. Participants felt more alert and made fewer cognitive errors within 30 minutes of consuming unbuzzd, significantly outperforming placebo results.
unbuzzd lessened the elevation in heart rate and the drop in blood pressure that often accompanies alcohol intoxication, stabilizing both. This result was statistically significant.
unbuzzd helped alleviate perceived impairment and mental fatigue caused by alcohol intoxication.
Participants in this study noted a statistically significant reduction in hangover symptoms. This included reduced cognitive and physical impairment, and reduced headache compared to placebo results, at both four hours (67 percent reduction in headache severity) and eight hours after consuming unbuzzd.

The Science

How it works

Richard Buzbuzian

CHIEF EXECUTIVE OFFICER
Capital markets executive with experience in Canada and Europe. Mr. Buzbuzian was a cofounder, a major shareholder, and the President of Drone Delivery Canada (FLT: TSXV), and was instrumental in raising $120M of equity financing. Mr. Buzbuzian holds a degree from the University of Toronto.

John Duffy

PRODUCT CONSULTANT
Over 30 years in the Consumer-Packaged Goods (CPG) industry. 22 years at Coca-Cola, Vice President of Marketing Assets and Vice President of National Sales. Co-founder LEGENDS Access. LA Libations, Vice President of Foodservice.

Gerry David

DIRECTOR, CO-CHAIR
Former CEO of Celsius Holdings, a zero-calorie fitness drink maker, 35-fold increase in market cap, surpassing $9B and enhancing shareholder value. One of 25 Gold Winners in the esteemed CEO World Awards.

Zeeshan Saeed

DIRECTOR, CO-CHAIR
Founder and current CEO, President and Executive Co-Chair of Quantum BioPharma President of ZZ Telecommunications, a long-distance communications carrier. Extensive experience in international capital markets, having successfully assisted multiple start-ups in raising initial funding and securing listings on various stock exchanges.

Dr. Lakshmi P. Kotra, B.Pharm. (Hons), PhD

DIRECTOR
Professor, Faculty of Pharmacy, University of Toronto, and Senior Scientist, University Health Network, where he led an active research group and drug discovery program with multiple portfolios. Academic entrepreneur contributing to a number of important drug discovery and development projects.

Dr. Eric Hoskins

DIRECTOR
Medical doctor and public health expert with 30+ years’ experience in healthcare, public policy, economic development and international trade. Former Ontario Minister of Health, in charge of running the largest healthcare system in North America. President of War Child Canada and was awarded the Order of Canada.

Dr. Andrzej Chruscinski, MD, PhD

RESEARCH & DEVELOPMENT
Dr. Chruscinski received his MD, and PhD from Stanford University, followed by residency in internal medicine at Stanford, fellowship in cardiology at Stanford and Toronto General. He is a board-certified cardiologist and carries an active medical license in Michigan.